U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula 2C19H19BrClNO2.C4H4O4
Molecular Weight 933.505
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of BERUPIPAM HEMIFUMARATE

SMILES

OC(=O)\C=C\C(O)=O.CN1CCC2=CC(Cl)=C(O)C=C2[C@H](C1)C3=CC(Br)=CC4=C3OCC4.CN5CCC6=CC(Cl)=C(O)C=C6[C@H](C5)C7=CC(Br)=CC8=C7OCC8

InChI

InChIKey=KAAMHRZPUYCDSD-ZMGYVUCRSA-N
InChI=1S/2C19H19BrClNO2.C4H4O4/c2*1-22-4-2-11-7-17(21)18(23)9-14(11)16(10-22)15-8-13(20)6-12-3-5-24-19(12)15;5-3(6)1-2-4(7)8/h2*6-9,16,23H,2-5,10H2,1H3;1-2H,(H,5,6)(H,7,8)/b;;2-1+/t2*16-;/m00./s1

HIDE SMILES / InChI
Molecular Formula C19H19BrClNO2
Molecular Weight 408.717
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED
Molecular Formula C4H4O4
Molecular Weight 116.0722
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 1
Optical Activity NONE

Description

Berupipam (also known as NNC 22-0010), a dopamine antagonist with a high affinity and selectivity for D1 receptor has been studied for patients with psychotic disorders. Berupipam participated in phase I clinical trials; however, further development of this drug was discontinued

Originator

Approval Year

Unknown
149124
PubMed

PubMed

TitleDatePubMed
Functional differentiation of multiple dopamine D1-like receptors by NNC 01-0012.
1998-10
11C- and 76Br-labelled NNC 22-0010, selective dopamine D1 receptor radioligands for PET.
1996-08
Characterization of benzazepine UDP-glucuronosyl-transferases in laboratory animals and man.
1995-06
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:02:23 GMT 2025
Edited
by admin
on Mon Mar 31 18:02:23 GMT 2025
Record UNII
VJ2NSAWU72
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BERUPIPAM HEMIFUMARATE
Common Name English
1H-3-BENZAZEPIN-7-OL, 5-(5-BROMO-2,3-DIHYDRO-7-BENZOFURANYL)-8-CHLORO-2,3,4,5-TETRAHYDRO-3-METHYL-, (5S)-, (2E)-2-BUTENEDIOATE (2:1) (SALT)
Preferred Name English
Code System Code Type Description
PUBCHEM
131634133
Created by admin on Mon Mar 31 18:02:23 GMT 2025 , Edited by admin on Mon Mar 31 18:02:23 GMT 2025
PRIMARY
CAS
172940-14-6
Created by admin on Mon Mar 31 18:02:23 GMT 2025 , Edited by admin on Mon Mar 31 18:02:23 GMT 2025
PRIMARY
FDA UNII
VJ2NSAWU72
Created by admin on Mon Mar 31 18:02:23 GMT 2025 , Edited by admin on Mon Mar 31 18:02:23 GMT 2025
PRIMARY
Related Record Type Details
Structure of BERUPIPAM
PARENT -> SALT/SOLVATE
Structure of Fumaric acid
PARENT -> SALT/SOLVATE
Related Record Type Details
Structure of BERUPIPAM
ACTIVE MOIETY
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966